Global healthcare company Abbott is launching NeuroSphere myPath, a digital health app designed to track and report on patient perceived pain relief and general wellbeing associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy.
During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trailing their neurostimulation therapy.
Abbott’s NeuroSphere myPath is a digital innovation that will provide relief to millions of Americans currently living with chronic pain that are eligible for SCS or DRG therapy.
This new digital health app will allow patients to use their Apple mobile device to connect with Abbott support, access educational resources and track the progress of their trial pain relief journey.
Keith Boettiger, vice president of neuromodulation at Abbott, says: “The COVID-19 pandemic put a spotlight on the need for digital and remote health tools. The launch of the NeuroSphere myPath is one more example of how Abbott has been leading the way in providing remote ways to connect doctors and patients.
Patients will be able to see information on their phone that would typically only be accessible in a doctor’s office—helping patients to share their journey with their doctors.”
Prior to committing to full implantation of a neuromodulation device, patients undergo a trial period to test device capabilities and capacity for pain relief.
During the trial, temporary leads are placed and connected to an external generator, allowing patients to experience first-hand the impact of neuromodulation on their chronic pain and related symptoms.
Shachi Patel, MD, interventional pain management physician and owner of Delmarva Pain and Spine Center in Newark, Delaware, says: “The current digital healthcare landscape has revolutionised our ability to provide direct care for patients whenever they need.
By providing patients with a more seamless, easier way to record their progress during the trial period, Abbott’s NeuroSphere myPath app will enable an enhanced communication experience while providing patients with further insight on their overall outcomes and response to neuromodulation.”
NeuroSphere myPath is the latest innovation that fits within Abbott’s broader NeuroSphere Digital Care connected health management platform.